Compound ID | 3491
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor. Aminoacyl-tRNA synthetase inhibitor (methionyl tRNA synthetase [MetRS] inhibitor) |
| Target Pathogen: | Active against methicillin-resistant and -susceptible Staphylococcus aureus, Enterococcus faecalis, vancomycin-resistant Enterococcus faecium, and Streptococcus pyogenes |
| Propensity to select resistant mutants: | Yes, 10^-9 (low; comparable to ciprofloxacin Staphylococcus aureus resistance frequencey rate) at 4x and 8x MIC |
| Description: | Synthetic compound; derived from MRS-2144; shows low mammalian cell line toxicity (safety margin by factor of 2 relative to MIC); shows comparable efficacy to linezolid when used in MRSA and Streptococcus infection in mice |
| Year first mentioned: | 2024 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/172606457 |
| Citation: | https://journals.asm.org/doi/10.1128/aac.00745-24 |